A highly sensitive europium nanoparticle-based immunoassay for detection of influenza A/B virus antigen in clinical specimens

Journal of Clinical Microbiology

Volumn 52, Issue 12, 2014, Pages 4385-4387

  Zhang, Panhe ^a   Vemula, Sai Vikram ^a   Zhao, Jiangqin ^a   Du, Bingchen ^a   Mohan, Haleyurgirisetty ^a   Liu, Jikun ^a   El Mubarak, Haja Sittana ^b   Landry, Marie L ^c   Hewlett, Indira ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EUROPIUM NANOPARTICLE; NANOPARTICLE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN; EUROPIUM;

ACCURACY; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPIUM NANOPARTICLE BASED IMMUNOASSAY; IMMUNOASSAY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; NONHUMAN; PROCESS DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS REACTIVATION; VIRUS STRAIN; COMPARATIVE STUDY; DIAGNOSTIC TEST; EVALUATION STUDY; HUMAN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; VIROLOGY;

ANTIGENS, VIRAL; DIAGNOSTIC TESTS, ROUTINE; EUROPIUM; HUMANS; IMMUNOASSAY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NANOPARTICLES; SENSITIVITY AND SPECIFICITY;

EID: 84910120554     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02635-14     Document Type: Article

References (22)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360: 2605-2615. http://dx.doi.org/10.1056/NEJMoa0903810.
2. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, Smith GJ. 2010. The emergence of pandemic influenza viruses. Protein Cell 1:9-13. http://dx .doi.org/10.1007/s13238-010-0008-z.
3. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. 2004. Influenza-associated hospitalizations in the United States. JAMA 292:1333-1340. http://dx.doi.org/10.1001/jama.292.11.1333.
4. Pandey A, Singh N, Vemula SV, Couetil L, Katz JM, Donis R, Sambhara S, Mittal SK. 2012. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus- based H5N1 influenza vaccine. PLoS One 7:e33428. http://dx.doi.org/10.1371/journal.pone.0033428.
5. Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK. 2013. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PLoS One 8:e62496. http://dx.doi.org/10.1371/journal.pone.0062496.
6. Vemula SV, Mittal SK. 2010. Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opin. Biol. Ther. 10:1469-1487. http://dx.doi.org/10.1517/14712598.2010.519332.
7. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186. http://dx.doi.org/10.1001/jama.289.2.179.
8. Liu J, Du B, Zhang P, Haleyurgirisetty M, Zhao J, Ragupathy V, Lee S, DeVoe DL, Hewlett IK. 2014. Development of a microchip europium nanoparticle immunoassay for sensitive point-of-careHIVdetection. Biosens. Bioelectron. 61:177-183. http://dx.doi.org/10.1016/j.bios.2014.04.057.
9. Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, Mirkin CA, Hewlett IK. 2007. Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J. Acquir. Immune Defic. Syndr. 46:231-237. http://dx.doi.org/10.1097/QAI.0b013e31814a554b.
10. Tang S, Hewlett I. 2010. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J. Infect. Dis. 201(Suppl 1):S59-S64. http://dx.doi.org/10.1086/650386.
11. Landry ML, Ferguson D. 2010. Cytospin-enhanced immunofluorescence and impact of sample quality on detection of novel swine origin (H1N1) influenza virus. J. Clin. Microbiol. 48:957-959. http://dx.doi.org/10.1128/JCM.01678-09.
12. Landry ML, Cohen S, Ferguson D. 2008. Real-time PCR compared to BinaxNOWand cytospin-immunofluorescence for detection of influenza in hospitalized patients. J. Clin. Virol. 43:148-151. http://dx.doi.org/10.1016/j.jcv.2008.06.006.
13. Landry ML, Ferguson D. 2014. Comparison of Simplexa Flu A/B & RSV PCR with cytospin-immunofluorescence and laboratory-developed Taq- Man PCR in predominantly adult hospitalized patients. J. Clin. Microbiol. 52:3057-3059. http://dx.doi.org/10.1128/JCM.00738-14.
14. Zhao J, Tang S, Storhoff J, Marla S, Bao YP, Wang X, Wong EY, Ragupathy V, Ye Z, Hewlett IK. 2010. Multiplexed, rapid detection of H5N1 using a PCR-free nanoparticle-based genomic microarray assay. BMC Biotechnol. 10:74. http://dx.doi.org/10.1186/1472-6750-10-74.
15. Zhao J, Wang X, Ragupathy V, Zhang P, Tang W, Ye Z, Eichelberger M, Hewlett I. 2012. Rapid detection and differentiation of swine-origin influenza A virus (H1N1/2009) from other seasonal influenza A viruses. Viruses. 4:3012-3019. http://dx.doi.org/10.3390/v4113012.
16. Centers for Disease Control and Prevention. 2009. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus - United States, 2009.MMWRMorb. Mortal. Wkly. Rep. 58:826-982.
17. Chartrand C, Pai M. 2012. How accurate are rapid influenza diagnostic tests? Expert Rev. Anti Infect. Ther. 10:615-617. http://dx.doi.org/10.1586/eri.12.49.
18. Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, Ferng YH, Morse SS, Larson EL, Aiello AE, Davis B, Monto AS. 2009. Low sensitivity of rapid diagnostic test for influenza. Clin. Infect. Dis. 48:e89-e92. http://dx.doi.org/10.1086/597828.
19. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. 2012. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann. Intern. Med. 156:500-511. http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00403.
20. Centers for Disease Control and Prevention. 2009. Interim guidance for the detection of novel influenza A virus using rapid influenza diagnostic tests. Centers for Disease Control and Prevention, Atlanta, GA.
21. Drexler JF, Helmer A, Kirberg H, Reber U, Panning M, Muller M, Hofling K, Matz B, Drosten C, Eis-Hubinger AM. 2009. Poor clinical sensitivity of rapid antigen test for influenzaApandemic(H1N1)2009 virus. Emerg. Infect. Dis. 15:1662-1664. http://dx.doi.org/10.3201/eid1510.091186.
22. Tang S, Moayeri M, Chen Z, Harma H, Zhao J, Hu H, Purcell RH, Leppla SH, Hewlett IK. 2009. Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles. Clin. Vaccine Immunol. 16:408-413. http://dx.doi.org/10.1128/CVI.00412-08.